Cita APA

Kristensen, L. K., Christensen, C. L., Jensen, M. M., Agnew, B., Schjöth-Frydendahl, C., Kjær, A., & Nielsen, C. H. (2019). Site-specifically labeled ⁸⁹Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model.

Citación estilo Chicago

Kristensen, Lotte K., Camilla L. Christensen, Mette Munk Jensen, Brian Agnew, Christina Schjöth-Frydendahl, Andreas Kjær, and Carsten H. Nielsen. Site-specifically Labeled ⁸⁹Zr-DFO-trastuzumab Improves Immuno-reactivity and Tumor Uptake for Immuno-PET in a Subcutaneous HER2-positive Xenograft Mouse Model. 2019.

Cita MLA

Kristensen, Lotte K., et al. Site-specifically Labeled ⁸⁹Zr-DFO-trastuzumab Improves Immuno-reactivity and Tumor Uptake for Immuno-PET in a Subcutaneous HER2-positive Xenograft Mouse Model. 2019.